Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study

BACKGROUND: Evidence accumulated that some glucose‐lowering medications protect against cardiovascular events (CVEs) in patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease. The present study evaluated if and how glucose‐lowering medication prescription pattern change...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadini, Gian Paolo, Frison, Vera, Simioni, Natalino, Lapolla, Annunziata, Gatti, Adriano, Bossi, Antonio Carlo, Del Buono, Andrea, Fornengo, Paolo, Gottardo, Lucia, Laudato, Mario, Perseghin, Gianluca, Bonora, Enzo, Avogaro, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662129/
https://www.ncbi.nlm.nih.gov/pubmed/31269877
http://dx.doi.org/10.1161/JAHA.119.012244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662129/
https://www.ncbi.nlm.nih.gov/pubmed/31269877
http://dx.doi.org/10.1161/JAHA.119.012244

Ejemplares similares